Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaspian Sunrise Regulatory News (CASP)

Share Price Information for Caspian Sunrise (CASP)

Share Price is delayed by 15 minutes
Get Live Data
2.10    0.00 (0.00%)
Bid:
2.00
Ask:
2.20
Spread: 0.20 (10.00%)
Market Cap: £49.48m
CASP Live PriceLast checked at - London Stock Exchange

Intraday Caspian Sunrise Share Chart

Shareholder Circular

27 Jul 2009 07:00

RNS Number : 2862W
Roxi Petroleum Plc
27 July 2009
 



Roxi Petroleum plc

("Roxi" or the "Company")

Shareholder Circular and Notice of General Meeting

The Company has today posted a circular to shareholders regarding the proposed sale of part of its interest in the BNG Contract Area. As announced on Friday 17 July regarding the extension of the sale agreement, under the terms of the agreement signed with Canamens and announced in January 2009 and because of the size of the proposed farm-out Roxi shareholder approval is required by 14 August 2009.

The Company will hold a General Meeting at 10am on 12 August.

The Circular is available on the Company's website at www.roxipetroleum.com 

The full text of the circular is inserted below

24 July 2009

 

Enquiries: 

Roxi Petroleum plc

Rob Schoonbrood, CEO +7 727 244 0920

College Hill (Financial PR)

Paddy Blewer / Nick Elwes +44 (0) 20 7457 2020

WH Ireland (NOMAD and broker)

James Joyce +44 (0)20 7220 1666

 

Dear Shareholder,

Disposal of part of BNG.

On 19 January 2009 Roxi Petroleum plc ("Roxi" or the "Company") announced that it had entered into a farm out agreement with Canamens BNG B.V. ("Canamens"), a non-related natural resources investment company, conditional on Roxi shareholder approval, to help fund the development of Roxi's 58.4% indirect interest in the BNG Contract Area assets, held through Roxi's BNG Energy B.V. subsidiary ("BNG B.V.") ("the Proposed Sale").

Under the AIM Rules the size of the assets to be sold compared to the market capitalisation of Roxi is such that Roxi shareholder approval is required to complete the agreement. Completion of the agreement is also subject to certain conditions being fulfilled, including the approval of the Company's shareholders.

The purpose of this circular is to set out the reasons why the Directors believe the Proposed Sale is in the best interests of the Company and to convene the General Meeting to consider the resolution required to complete the Proposed Sale.

 

Background

 

Roxi acquired its interest in the BNG Contract Area through the acquisition of Eragon Petroleum Limited ('Eragon') in March 2008. Under the obligations of the BNG work programme, Roxi is required to fund a minimum of $15.9 million in respect of the 2009 work programme and a further minimum $35.9 million in respect of the 2010 work programme.

Despite an extensive search for new investment during the summer and autumn of 2008, it was clear to the board, by late 2008, that Roxi was unlikely to be able to raise sufficient funds on appropriate terms from the conventional debt and equity markets to meet these obligations. Accordingly, the board sought finance from within the industry to maximise the value of the BNG Assets.

Canamens is well known to Roxi as a result of the sale of 32.5% of Roxi's interest in the Ravninnoe

Contract area to an affiliate of Canamens, which was announced on 19 November 2008 and approved by Roxi Shareholders in a General Meeting in December 2008.

The sale and purchase agreement with Canamens in respect of the BNG Contract Area was recently renegotiated and a new sale and purchase agreement was entered into on 1 July by the Company with Eragon, BNG B.V. and Canamens ('the Agreement'). The sale and purchase agreement was subsequently amended by an amendment agreement dated 17 July 2009.

Details of the Proposed Sale

Under the terms of the Agreement, completion is due to take place in 2 stages. At Stage 1 completion, Canamens commits to provide $27 million funding of the work programme to develop the BNG Contract Area and will pay BNG B.V. a performance bonus of $2 million provided that Stage 1 completion takes place on or before 14 August 2009. On completion, Canamens will receive 23% of BNG B.V.'s interest in the BNG Contract Area and will acquire 23% of Roxi and BNG B.V. loan receivables in respect of loans made to BNG ltd LLP.

Canamens may before 1 January 2010, elect to proceed to Stage 2 completion. Stage 2 completion is subject to the prior approval of the Company's shareholders. If Stage 2 completion takes place, Canamens will commit to provide $23 million funding of the work programme to further develop the BNG Contract Area for the sale of a further 12% of BNG B.V.'s interest in the BNG Contract Area and will acquire further 12% of Roxi and BNG BV loan receivables. Subject to completion of both stages, Roxi's interest in the BNG Contract Area will reduce to 37.96%.

To date, Canamens has advanced Roxi some $8 million of the amount due under Stage 1.

Recommendation

It is the view of all of the Directors of the Company, that the sale of this investment is in the best interests of the Company and recommend you vote in favour of the resolution to allow the Company to complete the Proposed Sale.

Attached hereto is a Notice of General Meeting of Shareholders and a Proxy Form.

Yours faithfully

CLIVE CARVER

CHAIRMAN

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOAPUUQCMUPBGQC
Date   Source Headline
3rd Sep 20247:00 amRNSProposed disposal of MJF & South Yelemes
2nd Sep 20242:27 pmRNSGeneral Update
18th Jul 20247:00 amRNSUpdate on Proposed Sale
15th Jul 20248:50 amRNSRestoration - Caspian Sunrise plc
15th Jul 20247:39 amRNSPosting of Accounts
15th Jul 20247:00 amRNSChange of Nominated Adviser and Broker
15th Jul 20247:00 amRNSAnnual Report for the Year Ended 31 December 2023
12th Jul 202412:38 pmRNSGeneral Update
8th Jul 20241:43 pmRNSUpdate
2nd Jul 20247:00 amRNSOperational Update
1st Jul 20247:30 amRNSSuspension - Caspian Sunrise plc
27th Jun 20243:42 pmRNSResult of AGM
27th Jun 20247:01 amRNSGeneral Update / AGM statement
27th Jun 20247:00 amRNSPreliminary Unaudited Results year end 31 Dec 2023
14th Jun 202410:42 amRNSReserve update
3rd Jun 20249:21 amRNS2024 AGM
14th May 20247:00 amRNSProposed Sale of the BNG shallow structures
25th Apr 20241:08 pmRNSGeneral Meeting Results
24th Apr 20247:00 amRNSIssue of Equity and Option Awards
8th Apr 20247:00 amRNSProposed Acquisition, Rule 9 Waiver and GM Notice
25th Mar 20247:00 amRNSStrategic & Operational Update
16th Feb 20247:00 amRNSBNG Operational update
21st Dec 20237:00 amRNSOperational Update
31st Oct 20237:00 amRNSOperational update
25th Sep 20237:00 amRNSInterim results for six months ended 30 June 2023
31st Jul 202312:49 pmRNSGM results
31st Jul 20237:00 amRNSGeneral Meeting & BNG and Caspian Explorer updates
11th Jul 202312:50 pmRNSHolding(s) in Company
10th Jul 20237:00 amRNSBoard change, Posting of the 2022 Results
7th Jul 20237:30 amRNSRestoration- Caspian Sunrise plc
7th Jul 20237:00 amRNSAnnual Report for the Year Ended 31 December 2022
3rd Jul 20237:30 amRNSSuspension - Caspian Sunrise plc
30th Jun 20233:51 pmRNSAGM results
30th Jun 20237:00 amRNSAGM Statement
12th Jun 20237:00 amRNS50% Sale of Caspian Explorer & Operational Update
1st Jun 20239:26 amRNSAGM and 2022 Accounts update
7th Mar 20237:00 amRNSCaspian Explorer contract signed & Dividend update
20th Feb 20237:00 amRNSCaspian Explorer update & Dividend update
30th Jan 20237:00 amRNSDeep well update
16th Jan 20234:40 pmRNSSecond Price Monitoring Extn
16th Jan 20234:35 pmRNSPrice Monitoring Extension
16th Jan 20232:05 pmRNSSecond Price Monitoring Extn
16th Jan 20232:00 pmRNSPrice Monitoring Extension
16th Jan 202311:05 amRNSSecond Price Monitoring Extn
16th Jan 202311:00 amRNSPrice Monitoring Extension
16th Jan 20237:00 amRNSTender Update
12th Jan 20237:00 amRNSThird Monthly Dividend Declaration
22nd Dec 20228:14 amRNSOperational Update
5th Dec 20227:00 amRNSSecond Monthly Dividend Declaration
11th Nov 20227:00 amRNSDividend Details

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.